(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Women take pride in Holy Week roles after a Spanish Catholic brotherhood's procession excluded them - 2An 'explosion' of solo-agers are struggling with rising costs and little support: 'I'm flying without a net'
- 3Addressing sleep apnea early might decrease chances of developing Parkinson's disease
- 4Top Frozen yogurt Flavor: Cast Your Vote!
- 5She loves to give experiences. He goes for sentimental gifts. They ask an expert: What is the perfect holiday present?
- 2026 Golden Globes: How to watch, start time, TV channel, full nominee list and more
- Remote Headphones: Upgrade Your Sound Insight
- Figure out How to Function Successfully with Your Auto Collision Legal advisor for the Best Result
- EU foreign ministers commemorate Russian massacre in Bucha
- Explainer-What has happened to the damaged spacecraft at China's space station?
- How will the universe end?
- Nutrient Rich Natural products: Lift Your Wellbeing
- At least 55 injured in Russia after train crashes, overturns
- 6 Famous Urban communities for Shopping on the planet
